Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Cell|March 13, 2025
Simultaneous CRISPR screening and spatial transcriptomics reveal intracellular, intercellular, and functional transcriptional circuitsLoϊc Binan, Aiping Jiang, Serwah A Danquah, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 11, 2022
Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.Acta Obstetricia Et Gynecologica Scandinavica|January 21, 2021
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional studyMichael Ceulemans, Veerle Foulon, Elin Ngo, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|November 17, 2022
The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1)Afif El-Khuffash, Patrick J McNamara, Colm Breatnach, et al.Maternal Health, Neonatology and Perinatology|December 8, 2018
The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literatureAfif El-Khuffash, Patrick J McNamara, Colm Breatnach, et al.Science Translational Medicine|February 23, 2021
Using viral load and epidemic dynamics to optimize pooled testing in resource-constrained settingsBrian Cleary, James A Hay, Brendan Blumenstiel, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settingsBrian Cleary, James A Hay, Brendan Blumenstiel, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 7, 2023
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.HRB Open Research|September 15, 2021
Early targeted patent ductus arteriosus treatment in premature neonates using a risk based severity score: study protocol for a randomised controlled trial (PDA RCT)Afif El-Khuffash, Neidin Bussmann, Colm R Breatnach, et al.The Journal of Pediatrics|October 18, 2020
A Pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT)Afif El-Khuffash, Neidín Bussmann, Colm R Breatnach, et al.Pageof 8